COMMUNIQUÉS West-GlobeNewswire

-
Herantis Pharma publishes newsletter for July-August
02/09/2019 -
Oxurion to make a late-breaker presentation of topline THR-149 (Plasma Kallikrein inhibitor) Phase 1 clinical data at EURETINA 2019
02/09/2019 -
Positive phase III results show Xofluza reduces risk of developing flu after contact with an infected person by 86%
02/09/2019 -
Roche presents positive phase III study results for one-dose Xofluza in children with flu
02/09/2019 -
Novartis PARAGON-HF trial suggests Entresto® benefit in HFpEF patients but narrowly misses primary endpoint
01/09/2019 -
Phase 2 data of aprocitentan, Idorsia’s dual endothelin receptor antagonist, presented at ESC 2019
31/08/2019 -
MyoKardia Presents 36-week Data from PIONEER-OLE Study of Mavacamten at the European Society of Cardiology Congress 2019
31/08/2019 -
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
31/08/2019 -
Dentsply Sirona to Present at the 2019 Baird Global Healthcare Conference on September 4th
30/08/2019 -
Eyecarrot to Participate in NORA 2019 Annual General Conference
30/08/2019 -
Protalix BioTherapeutics Receives Listing Deficiency Letter from NYSE American
30/08/2019 -
Bellicum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
30/08/2019 -
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
30/08/2019 -
Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
30/08/2019 -
Transparency notification
30/08/2019 -
Morphic to Present at the Wells Fargo Securities 2019 Healthcare Conference
30/08/2019 -
Idera Pharmaceuticals to Present at the Baird 2019 Global Healthcare Conference
30/08/2019 -
Vical Stockholders Approve Reverse Stock Split and Merger with Brickell
30/08/2019 -
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
30/08/2019
Pages